slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
16,03 CNY | +1,20% | +0,94% | +9,49% |
22/04 | Cisen Pharmaceutical Co. Rapporteert winstresultaten voor het eerste kwartaal eindigend op 31 maart 2024 | CI |
2023 | Cisen Pharmaceutical schrapt plan voor spin-off van eenheid | CI |
Vakgebied
Aantal werknemers: 3 402
Verkoop per activiteit
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Small Volume Injection
29,2
%
| 1 006 | 24,7 % | 1 301 | 29,2 % | +29,31% |
Large Infusion - Plastic Bottles
23,6
%
| 850 | 20,9 % | 1 053 | 23,6 % | +23,98% |
Large Infusion - Non-PVC Soft Bag
16,8
%
| 756 | 18,6 % | 749 | 16,8 % | -0,97% |
Oral Solid Dosage
10,7
%
| 470 | 11,6 % | 479 | 10,7 % | +1,82% |
Large Infusion - Glass Bottle
6,2
%
| 368 | 9,0 % | 277 | 6,2 % | -24,70% |
Ointment
4,2
%
| 186 | 4,6 % | 189 | 4,2 % | +1,56% |
Freeze-Dried Powder Injection
4,2
%
| 152 | 3,7 % | 186 | 4,2 % | +22,33% |
Drops
3,6
%
| 151 | 3,7 % | 160 | 3,6 % | +5,76% |
Original Ingredients
0,8
%
| 91 | 2,2 % | 37 | 0,8 % | -59,16% |
Flushing Agent
0,5
%
| 20 | 0,5 % | 21 | 0,5 % | +6,24% |
Others
0,2
%
| 1 | 0,0 % | 11 | 0,2 % | +1.927,84% |
Verkoop per regio
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
China
99,3
%
| 4 005 | 98,9 % | 4 419 | 99,3 % | +10,34% |
Foreign
0,7
%
| 44 | 1,1 % | 32 | 0,7 % | -27,44% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Zhen Xin Du
CEO | Chief Executive Officer | 57 | 06-11-98 |
En Long Zhao
CHM | Chairman | 45 | 01-07-04 |
Xin Bang Xu
DFI | Director of Finance/CFO | 46 | 01-08-00 |
Xiang Liu
BRD | Director/Board Member | 35 | 01-07-17 |
Yan Liu
BRD | Director/Board Member | 39 | 01-07-10 |
Xiu Lian Lu
BRD | Director/Board Member | 57 | 06-11-98 |
Liu Shan Hao
BRD | Director/Board Member | 54 | 06-11-98 |
Wei Sun
IRC | Investor Relations Contact | 42 | 08-12-20 |
Xiang Lin Zhang
PRN | Corporate Officer/Principal | 54 | 06-11-98 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Hong Zhang
BRD | Director/Board Member | 59 | 28-11-17 |
Zhen Xin Du
CEO | Chief Executive Officer | 57 | 06-11-98 |
Hong Cai
BRD | Director/Board Member | 63 | 08-12-20 |
Xin Sheng Sun
BRD | Director/Board Member | 71 | 28-11-17 |
Liu Shan Hao
BRD | Director/Board Member | 54 | 06-11-98 |
Xiu Lian Lu
BRD | Director/Board Member | 57 | 06-11-98 |
Xiang Lin Zhang
PRN | Corporate Officer/Principal | 54 | 06-11-98 |
Xin Bang Xu
DFI | Director of Finance/CFO | 46 | 01-08-00 |
En Long Zhao
CHM | Chairman | 45 | 01-07-04 |
Peng Mei Tian
BRD | Director/Board Member | 44 | 25-10-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 452 775 129 | 171 062 138 ( 37,78 %) | 10 500 ( 0,002319 %) | 37,78 % |
Bedrijfsgegevens
Cisen Pharmaceutical Ltd.
16, Tongji Road High-tech Zone
272073, Jining
+86 53 7298 9199
http://www.lkcisen.comSector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,49% | 1 mld. | |
+19,98% | 43,48 mld. | |
+20,67% | 22,65 mld. | |
+14,56% | 14,73 mld. | |
+14,32% | 13,79 mld. | |
+44,72% | 12,04 mld. | |
-8,37% | 7,08 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+11,90% | 5,47 mld. |
- Beurs
- Aandelen
- Koers 603367
- Onderneming Cisen Pharmaceutical Co., Ltd.